Testing effectiveness (Phase 2)Study completedNCT05081674What this trial is testingBrazilian Lung Immunotherapy StudyWho this might be right forLung Neoplasm Hospital Israelita Albert Einstein 154
Early research (Phase 1)Ended earlyNCT03343613What this trial is testingLY3381916 Alone or in Combination With LY3300054 in Participants With Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more Eli Lilly and Company 60
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT03845296What this trial is testingRucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationLoss of Heterozygosity+8 more SWOG Cancer Research Network 64
Early research (Phase 1)Active Not RecruitingNCT05799274What this trial is testingSafety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsWho this might be right forHealthy VolunteersPancreatic Ductal AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+4 more Radiopharm Theranostics, Ltd 9
Early research (Phase 1)Ended earlyNCT05769959What this trial is testingStudy of RO7515629 in Participants With HLA-G Positive Solid TumorsWho this might be right forRenal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Ended earlyNCT06024174What this trial is testingBMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Large-scale testing (Phase 3)UnknownNCT02011997What this trial is testingComparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With MicroinvasionWho this might be right forNon-small Cell Lung Cancer Stage ILung Adenocarcinoma The First Affiliated Hospital of Guangzhou Medical University 500
Not applicableLooking for participantsNCT05703516What this trial is testingA Post Approval Commitment Study on Tabrecta® (Capmatinib) in South KoreaWho this might be right forNon-Small-Cell Lung Carcinoma Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013What this trial is testingA Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursWho this might be right forBladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more Cancer Research UK 81
Testing effectiveness (Phase 2)Study completedNCT00633789What this trial is testingPhase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor TypesWho this might be right forAdvanced Non-small Cell Lung CancerTransitional Cell CarcinomaSoft Tissue Sarcoma+2 more Bristol-Myers Squibb 597
Early research (Phase 1)UnknownNCT04149691What this trial is testingSafety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesWho this might be right forGastric CancerBladder CancerSquamous Non-small Cell Lung Cancer+4 more Celon Pharma SA 42
Testing effectiveness (Phase 2)Study completedNCT00033384What this trial is testingCI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more University of Alabama at Birmingham
Testing effectiveness (Phase 2)Ended earlyNCT06739252What this trial is testingPerioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCAWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma Peking University 1
Testing effectiveness (Phase 2)Looking for participantsNCT04803318What this trial is testingTrametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid TumorsWho this might be right forSolid Tumor, AdultHepatocellular Carcinoma Second Affiliated Hospital of Guangzhou Medical University 100
Not applicableStudy completedNCT00499447What this trial is testingRadiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung Cancer Wake Forest University Health Sciences 13
Testing effectiveness (Phase 2)UnknownNCT03240549What this trial is testingEffectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable DiseaseWho this might be right forNon-small Cell Lung Cancer Metastatic Beijing Hospital 159
Testing effectiveness (Phase 2)Study completedNCT02992912What this trial is testingAtezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic TumoursWho this might be right forPatients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma ) Gustave Roussy, Cancer Campus, Grand Paris 138
Not applicableActive Not RecruitingNCT02119065What this trial is testingPilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CTWho this might be right forAdvanced Adult Primary Liver CancerLiver MetastasesLocalized Unresectable Adult Primary Liver Cancer+1 more University of Cincinnati 6